BNA™ History
Here we introduce BNA™ history.
1997 | the 1st generation of bridged nucleic acid/2',4'-BNA(LNA) was developed by Dr. Takeshi Imanshi (Professor, Faculty of Pharmaceutical Sciences, Osaka University) et al. |
2',4'-BNA(LNA)
![サンプル](/dcms_media/image/LNA.png)
2002 | the 2nd generation of bridged nucleic acid/2',4'-BNACOC was developed. |
2',4'-BNACOC
![BNACOC.png](/dcms_media/image/BNACOC.png)
2003 | the 3rd generation of bridged nucleic acid/2',4'-BNANC was developed. |
2',4'-BNANC
![サンプル](/dcms_media/image/BNANC.png)
2008 | BNA Inc. Established (founder: Dr.Takeshi Imanishi (Professor Emeritus, Osaka University)), BNA Inc. launched 2',4'-BNANC amidites. |
![サンプル](/dcms_media/image/BNA%E3%82%A2%E3%83%9F%E3%83%80%E3%82%A4%E3%83%88.jpg)
2012 | BNA Clamp PCR method was developed |
![サンプル](/dcms_media/image/BNA%E3%82%AF%E3%83%A9%E3%83%B3%E3%83%97%E8%A3%BD%E5%93%81.jpg)
2014 | BNA Inc. became a subsidiary of RIKEN GENESIS Co., Ltd. |
2019 | Dr. Takeshi Imanishi (BNA adviser) was received The Award of Japan Society of Nucleic Acids Chemistry (Ikehara Award) . |
2021 | BNA Inc. was merged by RIKEN GENESIS Co., Ltd. |